Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 29
Filter
1.
Journal of Southern Medical University ; (12): 544-551, 2023.
Article in Chinese | WPRIM | ID: wpr-986960

ABSTRACT

OBJECTIVE@#To analyze the expression of hydroxysteroid dehydrogenase like 2 (HSDL2) in rectal cancer tissues and the effect of changes in HSDL2 expression level on proliferation of rectal cancer cells.@*METHODS@#Clinical data and tissue samples of 90 patients with rectal cancer admitted to our hospital from January 2020 to June 2022 were collected from the prospective clinical database and biological specimen database. The expression level of HSDL2 in rectal cancer and adjacent tissues was detected by immunohistochemistry, and based on the median level of HSDL2 expression, the patients were divided into high expression group (n=45) and low expression group (n=45) for analysis the correlation between HSDL2 expression level and the clinicopathological parameters. GO and KEGG enrichment analyses were performed to explore the role of HSDL2 in rectal cancer progression. The effects of changes in HSDL2 expression levels on rectal cancer cell proliferation, cell cycle and protein expressions were investigated in SW480 cells with lentivirus-mediated HSDL2 silencing or HSDL2 overexpression using CCK-8 assay, flow cytometry and Western blotting.@*RESULTS@#The expressions of HSDL2 and Ki67 were significantly higher in rectal cancer tissues than in the adjacent tissues (P < 0.05). Spearman correlation analysis showed that the expression of HSDL2 protein was positively correlated with Ki67, CEA and CA19-9 expressions (P < 0.01). The rectal cancer patients with high HSDL2 expressions had significantly higher likelihood of having CEA ≥5 μg/L, CA19-9 ≥37 kU/L, T3-4 stage, and N2-3 stage than those with a low HSDL2 expression (P < 0.05). GO and KEGG analysis showed that HSDL2 was mainly enriched in DNA replication and cell cycle. In SW480 cells, HSDL2 overexpression significantly promoted cell proliferation, increased cell percentage in S phase, and enhanced the expression levels of CDK6 and cyclinD1 (P < 0.05), and HSDL2 silencing produced the opposite effects (P < 0.05).@*CONCLUSION@#The high expression of HSDL2 in rectal cancer participates in malignant progression of the tumor by promoting the proliferation and cell cycle progress of the cancer cells.


Subject(s)
Humans , CA-19-9 Antigen , Ki-67 Antigen/metabolism , Prospective Studies , Cell Line, Tumor , Cell Proliferation/genetics , Rectal Neoplasms/genetics , Cell Cycle , Gene Expression Regulation, Neoplastic , Hydroxysteroid Dehydrogenases/metabolism
2.
Environmental Health and Toxicology ; : e2016010-2016.
Article in English | WPRIM | ID: wpr-162229

ABSTRACT

OBJECTIVES: Aromatase inhibitors that block estrogen synthesis are a proven first-line hormonal therapy for postmenopausal breast cancer. Although it is known that standardized extract of Ginkgo biloba (EGb761) induces anti-carcinogenic effects like the aromatase inhibitors, the effects of EGb761 on steroidogenesis have not been studied yet. Therefore, the effects of EGb761 on steroidogenesis and aromatase activity was studied using a H295R cell model, which was a good in vitro model to predict effects on human adrenal steroidogenesis. METHODS: Cortisol, aldosterone, testosterone, and 17β-estradiol were evaluated in the H295R cells by competitive enzyme-linked immunospecific assay after exposure to EGb761. Real-time polymerase chain reaction were performed to evaluate effects on critical genes in steroid hormone production, specifically cytochrome P450 (CYP11/17/19/21) and the hydroxysteroid dehydrogenases (3β-HSD2 and 17β-HSD1/4). Finally, aromatase activities were measured with a tritiated water-release assay and by western blotting analysis. RESULTS: H295R cells exposed to EGb761 (10 and 100 μg/mL) showed a significant decrease in 17β-estradiol and testosterone, but no change in aldosterone or cortisol. Genes (CYP19 and 17β-HSD1) related to the estrogen steroidogenesis were significantly decreased by EGb761. EGb761 treatment of H295R cells resulted in a significant decrease of aromatase activity as measured by the direct and indirect assays. The coding sequence/ Exon PII of CYP19 gene transcript and protein level of CYP19 were significantly decreased by EGb761. CONCLUSIONS: These results suggest that EGb761 could regulate steroidogenesis-related genes such as CYP19 and 17β-HSD1, and lead to a decrease in 17β-estradiol and testosterone. The present study provides good information on potential therapeutic effects of EGb761 on estrogen dependent breast cancer.


Subject(s)
Humans , Adrenocortical Carcinoma , Aldosterone , Anticarcinogenic Agents , Aromatase Inhibitors , Aromatase , Blotting, Western , Breast Neoplasms , Clinical Coding , Cytochrome P-450 Enzyme System , Estrogens , Exons , Ginkgo biloba , Hydrocortisone , Hydroxysteroid Dehydrogenases , In Vitro Techniques , Real-Time Polymerase Chain Reaction , Testosterone , Therapeutic Uses
3.
Arq. neuropsiquiatr ; 73(2): 140-146, 02/2015. tab, graf
Article in English | LILACS | ID: lil-741179

ABSTRACT

The objective of this article is to highlight some of the most important pioneering books specifically focused on the neurological examination and their authors. During the XIX Century, Alexander Hammond, William Gowers and Charles Mills pioneered the neurological literature, followed in the XX Century by Aloysio de Castro, Monrad-Krohn, Derek Denny-Brown, Robert Wartenberg, Gordon Holmes, and Russel DeJong. With determination and a marked sense of observation and research, they competently developed and spread the technique and art of the neurological exam.


O objetivo deste artigo é destacar alguns dos primeiros e mais importantes livros-texto interessados em difundir o ensino do exame neurológico e seus autores. Durante o século XIX, Alexander Hammond, William Gowers e Charles Mills foram pioneiros na literatura neurológica, seguidos por Aloysio de Castro, Monrad-Krohn, Derek Denny-Brown, Robert Wartenberg, Gordon Holmes e Russel DeJong no século XX. Com determinação, grande senso de observação e pesquisa, eles competentemente disseminaram a técnica e a arte de se realizar o exame neurológico.


Subject(s)
Animals , Female , Pregnancy , Betamethasone/pharmacology , Gestational Age , Glucocorticoids/pharmacology , Hydroxysteroid Dehydrogenases/analysis , Placenta/enzymology , Blotting, Northern , Blotting, Western , Fetal Blood/chemistry , Hydrocortisone/blood , Hydroxysteroid Dehydrogenases/genetics , Labor, Obstetric/physiology , Papio , RNA, Messenger/analysis
4.
Rev. bras. ginecol. obstet ; 37(1): 30-35, 01/2015. tab
Article in Portuguese | LILACS | ID: lil-732873

ABSTRACT

OBJETIVO: Avaliar a prevalência da baixa densidade mineral óssea (DMO) em mulheres na pós-menopausa tratadas de câncer de mama. MÉTODOS: Estudo de corte transversal que incluiu 115 mulheres tratadas de câncer de mama atendidas em Hospital Universitário do Sudeste do Brasil. Foram incluídas mulheres com amenorreia há 12 meses ou mais e 45 anos ou mais de idade, tratadas de câncer de mama e livres de doença há pelo menos 5 anos. A DMO foi mensurada pelos raios-X de dupla energia em coluna lombar (L1 a L4) e colo de fêmur. Considerou-se baixa DMO quando valores de T-score de coluna total e/ou colo de fêmur <-1,0 Score de Delphi (DP) (osteopenia e osteoporose). Por meio de entrevista, foram avaliados fatores de risco para baixa DMO. Na análise estatística, empregaram-se os testes do χ2 ou Exato de Fisher. RESULTADOS: A média de idade das pacientes foi 61,6±10,1 anos e o tempo de menopausa, 14,2±5,6 anos, com tempo médio de seguimento de 10,1±3,9 anos. Considerando coluna e colo de fêmur, 60% das mulheres tratadas de câncer de mama apresentavam baixa DMO. Avaliando os fatores de risco para baixa DMO, foi encontrada diferença significativa na distribuição percentual quanto à idade (maior porcentagem de mulheres com mais de 50 anos e baixa DMO), história pessoal de fratura prévia (11,6% com baixa DMO e nenhuma com DMO normal) e índice de massa corpórea. Maior frequência de obesidade foi observada entre mulheres com DMO normal (63%) quando comparadas àquelas com baixa DMO (26,1%; p<0,05). CONCLUSÃO: Mulheres na pós-menopausa tratadas de câncer de mama apresentaram elevada prevalência de baixa DMO (osteopenia e/ou osteoporose). .


PURPOSE: To evaluate the prevalence of low bone mineral density (BMD) in postmenopausal breast cancer survivors. METHODS: In this cross-sectional study, 115 breast cancer survivors, seeking healthcare at a University Hospital in Brazil, were evaluated. Eligibility criteria included women with amenorrhea ≥12 months and age ≥45 years, treated for breast cancer and metastasis-free for at least five years. BMD was measured by DEXA at the lumbar spine (L1-L4) and femoral neck. Low BMD was considered when total-spine and/or femoral-neck T-score values were <-1.0 Delphi Score (DP) (osteopenia and osteoporosis). The risk factors for low BMD were assessed by interview. Data were analyzed statistically by the χ2 test and Fisher's exact test. RESULTS: The mean age of breast cancer survivors was 61.6±10.1 years and time since menopause was 14.2±5.6 years, with a mean follow-up of 10.1±3.9 years. Considering spine and femoral neck, 60% of breast cancer survivors had low BMD. By evaluating the risk factors for low BMD, a significant difference was found in the percent distribution for age (higher % of women >50 years with low BMD), personal history of previous fracture (11.6% with low BMD versus 0% with normal BMD) and BMI. A higher frequency of obesity was observed among women with normal BMD (63%) compared to those with low BMD (26.1%) (p<0.05). CONCLUSION: Postmenopausal breast cancer survivors had a high prevalence of osteopenia and osteoporosis. .


Subject(s)
Animals , Rats , Bile Acids and Salts/metabolism , Bile Canaliculi/metabolism , Carrier Proteins/metabolism , Hydroxysteroid Dehydrogenases , Membrane Glycoproteins , Adenosine Triphosphatases/metabolism , Biological Transport , COS Cells , Carcinoembryonic Antigen/biosynthesis , Carrier Proteins/biosynthesis , DNA Primers , DNA, Complementary , Ileum/metabolism , Kinetics , Mutagenesis, Site-Directed , Recombinant Fusion Proteins/biosynthesis , Recombinant Fusion Proteins/metabolism , Transfection , Taurocholic Acid/metabolism
5.
National Journal of Andrology ; (12): 371-376, 2008.
Article in Chinese | WPRIM | ID: wpr-319249

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the effects of Ginkgo biloba extract (EGB) on the testosterone synthesis in the Leydig cells of type 2 diabetic rats.</p><p><b>METHODS</b>Thirty male SD rats were equally randomised into a normal control, a type 2 diabetic and an EGB group. Morphological changes of Leydig cells were observed by light microscopy (LM) and transmission electron microscopy (TEM), concentrations of serum luteinizing hormone (LH) and testosterone (T) were determined by enzyme linked immunosorbent assay (ELISA), and the mRNA levels in the steroidogenic acute regulatory protein (StAR), cytochrome P450 side chain cleavage (P450scc), cytochrome P450 17a-hydroxylase (P450c17), 17beta-hydroxysteroid dehydrogenase 3 (17beta-HSD3) and 3beta-hydroxysteroid dehydrogenase (3beta-HSD1) from the Leydig cells were examined by RT-PCR.</p><p><b>RESULTS</b>Compared with the normal control, there was a significant decrease in the number and volume of Leydig cells, the levels of serum LH and T and the expression of mRNA in StAR, P450scc, 17beta-HSD3 and 3beta-HSD1 in the type 2 diabetes group. And the expression of the P450c17 gene showed a tendency of descending, but with no significance. Compared with the type 2 diabetes group, 12 weeks of EGB treatment caused very slight pathological changes in the Leydig cells, significantly increased the concentrations of blood LH and T, markedly elevated the levels of mRNA in StAR and P450scc and induced an ascending tendency of the expressions of P450c17, 17beta-HSD3 and 3beta-HSD1.</p><p><b>CONCLUSION</b>EGB enhances testosterone synthesis and secretion of Leydig cells by reducing the impairment of the testis in type 2 diabetic rats.</p>


Subject(s)
Animals , Male , Rats , 17-Hydroxysteroid Dehydrogenases , Genetics , Cholesterol Side-Chain Cleavage Enzyme , Genetics , Diabetes Mellitus, Type 2 , Blood , Genetics , Enzyme-Linked Immunosorbent Assay , Gene Expression , Ginkgo biloba , Chemistry , Hydroxysteroid Dehydrogenases , Genetics , Leydig Cells , Metabolism , Luteinizing Hormone , Blood , Microscopy, Electron, Transmission , Phosphoproteins , Genetics , Plant Extracts , Pharmacology , RNA, Messenger , Genetics , Metabolism , Rats, Sprague-Dawley , Reverse Transcriptase Polymerase Chain Reaction , Testosterone , Blood
6.
Iranian Journal of Veterinary Research. 2005; 6 (2): 54-61
in English | IMEMR | ID: emr-71194

ABSTRACT

Low-level pollution of aquatic ecosystems may decrease the fecundity of fish populations either indirectly via accumulation in the reproductive organs, or acting directly on sperm and ovum. The activity of highly active hydroxy steroid dehydrogenase [HSD] enzyme in fish sperm has been used as indicator of water contamination with zinc, cadmium or zinc + cadmium. Three groups of six male African catfish were fed from the sexually immature juvenile stage, with diet containing 1000 ppm zinc, cadmium or zinc + cadmium for 110 days and 20 alpha HSD activity in milt of these fish were compared with six other control fish fed with normal diet. The 20 alpha HSD enzyme activity was also measured in in vitro incubation of milt from six control fish with different concentrations [0, 0.1, 1, 3, 10, 30, 100, 1000 and 3000 ppm] of zinc, cadmium or zinc + cadmium. A very high 20 alpha hydroxy steroid dehydrogenase enzyme activity was found in all sperm incubations of African catfish. This enzyme converts 17-hydroxy progesterone [17P] substrate to 17,20 alpha-dihydroxy progesterone [1720 alpha P] product and the rate of enzyme activity is related to substrate [17P] concentrations. Significant differences [P<0.05] in enzyme activity in converting 17P to 17,20 alpha P were found between in vitro incubations of sperm with different concentrations of zinc, cadmium or zinc + cadmium and control group [0 ppm]. Significant differences [P<0.05] in enzyme activity and 17,20 alpha P production were found between fish fed with diet containing 1000 ppm zinc or cadmium and the group fed with diet containing 1000 ppm zinc + cadmium and control groups. The results showed that 20 alpha HSD enzyme activities in fish sperm may be used as indicator of water contamination with heavy metals and their bioaccumulations in testis of aquatic animals


Subject(s)
Animals , Zinc/administration & dosage , Cadmium/administration & dosage , Catfishes , Water Pollution , Hydroxysteroid Dehydrogenases , 17-alpha-Hydroxyprogesterone
7.
Indian J Exp Biol ; 2004 Feb; 42(2): 143-8
Article in English | IMSEAR | ID: sea-60643

ABSTRACT

Effects of lead (Pb) and cadmium (Cd) both alone or in combination on the binding of LH and FSH on isolated granulosa cells were studied. Granulosa cells isolated from proestrous rats were incubated (in vitro) with lead acetate and/or cadmium acetate (0.03 microM of Pb or Cd) for 1 hr. LH binding was dropped to 84% in Pb treated cells, 72.5% in Cd treated cells and 74.8% in combined metal treated cells compared to control. FSH binding dropped to 85.5% in Pb treated cells, 71.16% in Cd treated cells and 72.5% in combined metal treated cells compared to control. Activity of 17beta Hydroxy Steroid Dehydrogenase (17betaHSDH), a key steroidogenic enzyme was reduced by 52% in Cd and 37% in combined metal exposed cells whereas Pb exposed cells showed 31% reduction in the enzyme activity. Pretreatment with SH groups protectants (glutathione [GSH], dithiothretol [DTT]) and zinc caused an ameriolation in enzyme activity whereas Zn pretreatment showed an increase in gonadotropin binding in metal exposed cells. These results suggest that both Pb and Cd can cause a reduction in LH and FSH binding, which significantly alters steroid production in vitro and exerts a direct influence on granulosa cell function.


Subject(s)
Animals , Cadmium/toxicity , Dithiothreitol/pharmacology , Drug Combinations , Female , Follicle Stimulating Hormone/metabolism , Glutathione/pharmacology , Granulosa Cells/drug effects , Hydroxysteroid Dehydrogenases/metabolism , Lead/toxicity , Luteinizing Hormone/metabolism , Proestrus/drug effects , Rats , Steroids/biosynthesis , Zinc/pharmacology
8.
IJMS-Iranian Journal of Medical Sciences. 2004; 29 (4): 175-179
in English | IMEMR | ID: emr-66042

ABSTRACT

Aqueous extract of winter cherry [Physalis alkekengi L; family of Solanaceae] fruits [WCF] has long been recommended for fertility control by herbalists in Iran. The effect of this extract on lowering serum progesterone levels has been reported previously. To study the effects of WCF extract on the activities of ovarian 3 [3-hydroxy steroid dehydrogenase [3beta-HSD] responsible for the synthesis of progesterone and 20 alpha-HSD responsible for its degradation in rats. One ml aliquots of the aqueous extract of WCF [containing 400 mg of dried extract] were intraperitoneally injected for 8 consecutive days to rats from day 8 of pregnancy. Rats were then sacrificed 21 days and 11 hours after the day of observing sperm positive vaginal smears. Blood was collected for the determination of serum progesterone and the total and the live numbers of embryos were counted. Ovaries were also used for the measurement of the activities of 3beta- and 20 alpha -HSD. The extract of WCF decreased the ovarian 3beta-HSD specific activity by 47%, serum progesterone concentration by 30% and the number of live embryos by 67%, but it had no effect on the specific activity of ovarian 20alpha-HSD. The aqueous extract of WCF, containing steroidal compounds with known estrogen antagonistic properties, probably interferes with the function of estradiol in inducing ovarian 3beta-HSD synthesis. It may also contain components which inhibit this enzyme, thus reducing progesterone synthesis that is required for maintaining pregnancy. Such natural compounds, if purified, might be beneficial for control of fertility


Subject(s)
Animals, Laboratory , Plant Extracts , Hydroxysteroid Dehydrogenases/drug effects , Ovary , Pregnancy, Animal , Rats, Sprague-Dawley , Fruit
9.
Rev. méd. Chile ; 130(11): 1201-1208, nov. 2002. ilus, tab, graf
Article in Spanish | LILACS | ID: lil-340218

ABSTRACT

Background: Half of hypertensive patients with low plasma renin activity have a primary hyperaldosteronism. Among the remaining half, 11ß-hydroxysteroid dehydrogenase type 2 (11ßHSD2) deficiency plays an important role. This enzyme catalyzes the conversion of cortisol to cortisone, avoiding the interaction of cortisol with the mineralocorticoid receptor. If the enzyme fails, cortisol will stimulate sodium and water reabsorption and increase blood pressure. Aim: To determine biochemical alterations, suggestive of 11ßHSD2 deficiency, in low-renin hypertensive patients. Patients and Methods: Twenty eight hypertensive patients with a plasma renin activity of less than 0.5 ng/ml/h and with a plasma aldosterone of less than 5 ng/dl were studied. Twenty eight normotensive patients were studied as controls. Serum cortisol (RIA), cortisone (ELISA) and the serum cortisol/cortisone ratio were determined in all of them, between 9 and 10 AM. Measurements were confirmed by high pressure liquid chromatography. The serum cortisol/cortisone ratio was considered abnormal when its Ln (cortisol/cortisone) value was over 2 standard deviations of the mean. Results: Serum cortisol was higher in hypertensive subjects than in controls (11.1ñ3.3 and 9.2ñ2.8 µg/dl, respectively; p <0.05). No differences were observed in serum cortisone (3.4ñ1.3 and 3.7ñ1.2 µg/dl, respectively). Four hypertensive subjects had an abnormally high Ln (cortisol/cortisone) value (1.86; 1.73; 2.07 and 2.01, considering a normal value of less than 1.61). Conclusions: Four of 28 hypertensive subjects with low plasma renin activity and aldosterone had biochemical alterations suggestive of 11ßHSD2 deficiency


Subject(s)
Humans , Male , Adult , Female , Middle Aged , Hydroxysteroid Dehydrogenases , Hypertension/complications , Cortisone , Hydrocortisone , Hypoaldosteronism , Hyperaldosteronism
10.
Medical Journal of Islamic World Academy of Sciences. 2002; 12 (1): 25-8
in English | IMEMR | ID: emr-60082
11.
Asian Journal of Andrology ; (6): 201-207, 2002.
Article in English | WPRIM | ID: wpr-284048

ABSTRACT

<p><b>AIM</b>To study the detrimental effects of cyclophosphamide on the testicular androgenic and gametogenic activities through endocrine inhibition and/or induction of oxidative stress in male albino rats and to evaluate the protective effect of ascorbic acid.</p><p><b>METHODS</b>The testicular D5, 3b-hydroxysteroid dehydrogenase (HSD), 17b-HSD, peroxidase and catalase activities along with the levels of malondialdehyde (MDA) and conjugated dienes in testicular tissue were measured for the evaluation of testicular oxidative stress. The plasma testosterone (T) level was measured by immunoassay. Various germ cells at stage VII of spermatogenic cycle were quantified from testicular stained sections.</p><p><b>RESULTS</b>Cyclophosphamide treatment results in a significant inhibition in the testicular D5, 3b-HSD and 17b-HSD activities, a decrease in plasma T level and a diminution in the counts of various germ cells. Moreover, this treatment was also associated with a significant inhibition of the peroxidase and catalase activities along with high levels of MDA and conjugated dienes in the testis. All these changes were reversed by ascorbic acid co-administration.</p><p><b>CONCLUSION</b>Cyclophosphamide treatment at the dosage used caused testicular gametogenic and androgenic disorders as well as induced testicular oxidative stress that can be reversed by ascorbic acid co-administration.</p>


Subject(s)
Animals , Male , Rats , Antioxidants , Pharmacology , Ascorbic Acid , Pharmacology , Body Weight , Catalase , Metabolism , Cyclophosphamide , Pharmacology , Hydroxysteroid Dehydrogenases , Metabolism , Infertility, Male , Drug Therapy , Lipid Peroxidation , Mutagens , Pharmacology , Peroxidase , Metabolism , Rats, Wistar , Spermatogenesis , Testosterone , Blood
12.
Indian J Exp Biol ; 2001 Dec; 39(12): 1249-53
Article in English | IMSEAR | ID: sea-60714

ABSTRACT

Adult male rats received daily injections (sc) of gonadotropin releasing hormone antagonist (0.2 mg/kg(-1) x day(-1)) for 21 days when they were sacrificed on day 22, adrenal weight, adrenal A5-3beta (delta 5-3beta) hydroxysteroid dehydrogenase (Delta5-3beta-HSD) activity and serum level of corticosterone were increased significantly while testicular 17beta (17beta) hydroxysteroid dehydrogenase (17beta-HSD) activity and serum level of testosterone and spermatogenesis were decreased in the rats fed on 5% casein diet. GnRH antagonist treated rats fed on 20% casein diet, resulted significant decrease in adrenal weight, serum corticosterone and adrenal A5-3beta-HSD activity while testicular 17beta-HSD activity serum testosterone levels and the weights of sex organs were increased with respect to anti GnRH treated rats fed on 5% casein diet. But the GnRH antagonist treated rats fed on 20% casein diet showed decreased spermatogenesis quantitatively and sperm count appeared similar to anti GnRH treated rats fed on 5% casein diet. These results indicate that high casein diet protects adrenocortical activity and stimulates testosterone synthesis without effecting spermatogenic arrest in GnRH antagonist treated rats. It may be concluded that GnRH antagonist in presence of high milk protein diet may be considered to be a suitable antihormone in the development of an ideal male contraceptive.


Subject(s)
Adrenal Glands/enzymology , Animals , Caseins/administration & dosage , Dietary Proteins/administration & dosage , Gonadotropin-Releasing Hormone/antagonists & inhibitors , Hydroxysteroid Dehydrogenases/metabolism , Male , Rats , Rats, Wistar , Spermatogenesis , Testis/enzymology
13.
Rev. méd. Chile ; 128(1): 17-26, ene. 2000. graf
Article in Spanish | LILACS | ID: lil-258083

ABSTRACT

An 11-year old girl was seen in 1981 with hypokalemia, low renin, low aldosterone, and severe hypertension. A medical adrenalectomy with dexamethasone and aminoglutethimide, and the blockade of mineralocorticoid receptors with spironolactone improved her condition, but the blockade of glucocorticoid receptors with RU-486 worsened it. An aldosterone infusion induced no changes. A sister was born in 1982 with similar findings. Both patients had an impaired ability to convert cortisol to cortisone after an oral load of 200 mg cortisol. In urine, an elevated ratio for metabolites of cortisol to metabolites of cortisone was found. These data suggested a defect in the activity of renal 11ß-hydroxysteroid dehydrogenase. Both parents were asymptomatic, phenotypically normal and non-consanguineous. Their urinary metabolites of cortisol and cortisone were normal before and after stimulation with ACTH. However, the mother reached a peak plasma cortisone concentration 3 SD below the mean reached by normal subjects after an oral 200-mg cortisol load, a fact that suggests that this test could be used to detect heterozygotes. The genetic studies revealed a homozygous mutation on exon 3 of the HSD11K gene, which by substituting TGC for CGC changes Arg 213 for Cys and induces a loss of 84 percent of the enzymatic activity in transfected cells. Both unrelated parents had the same heterozygous mutation. Both patients have been treated with dexamethasone but have also required spironolactone. The older sister has also required high doses of nifedipine to lower her blood pressure. After 19 years of follow-up, the older sister has become normotensive and normokalemic under therapy, and reached a final height of 140 cm at age 17. The younger sister has increased her mean blood pressure at a rate of 1 mm Hg per year, in spite of treatment. Her final height is 143.5 cm


Subject(s)
Humans , Male , Female , Adult , Adolescent , Hydroxysteroid Dehydrogenases/deficiency , Mineralocorticoids , Hypertension/congenital , Spironolactone/administration & dosage , Cortisone/blood , Dexamethasone/administration & dosage , Hydrocortisone/blood , Nifedipine/administration & dosage , Mifepristone/administration & dosage , Aldosterone/administration & dosage
14.
Indian J Physiol Pharmacol ; 1994 Apr; 38(2): 141-2
Article in English | IMSEAR | ID: sea-106950

ABSTRACT

Mitomycin C (MC), an antibiotic which depresses DNA synthesis causes suppression of enzyme delta 5 3 beta-hydroxysteroid dehydrogenase (delta 5 3 beta OHD) and glucose-6 phosphate dehydrogenase (G-6 PD) in the rat adrenal tissue. The treatment resulted in a fall in DNA content together with an accumulation of cholesterol and ascorbic acid in the gland. The results suggest a diminution in adrenal steroid biogenesis similar to gonadal inhibition previously reported.


Subject(s)
11-beta-Hydroxysteroid Dehydrogenases , Adrenal Glands/drug effects , Animals , Ascorbic Acid/metabolism , Cholesterol/metabolism , DNA/metabolism , Female , Glucosephosphate Dehydrogenase/metabolism , Hydroxysteroid Dehydrogenases/metabolism , Mitomycin/pharmacology , Rats , Rats, Wistar , Steroids/biosynthesis
15.
Indian J Physiol Pharmacol ; 1992 Jul; 36(3): 162-8
Article in English | IMSEAR | ID: sea-107178

ABSTRACT

Three groups of rats (n = 10) were subjected to intraperitoneal treatment of formaldehyde daily at doses of 5, 10 and 15 mg/kg body weight over a period of 30 days. Gradual diminution in body and testicular weight was observed in all treated groups. Leyding cell impairement was conspicuous in those given doses of 10 and 15 mg/kg. Inhibition of 3 beta-delta 5-hydroxy steroid dehydrogenase and accumulation of sudanophillic materials in testicular tissue of formaldehyde treated rats was recorded histochemically. Significant decline of serum testosterone was also observed in the same groups. Structural and functional impairement of Leydig cells after formaldehyde treatment caused steroidogenic inhibition.


Subject(s)
Animals , Body Weight/drug effects , Formaldehyde/administration & dosage , Hydroxysteroid Dehydrogenases/antagonists & inhibitors , Injections, Intraperitoneal , Leydig Cells/drug effects , Male , Organ Size/drug effects , Rats , Spermatogenesis/drug effects , Testis/drug effects , Testosterone/biosynthesis
16.
Rev. bras. ginecol. obstet ; 7(1): 15-8, jan.-fev. 1985. ilus
Article in Portuguese | LILACS | ID: lil-40801

ABSTRACT

Estudaram-se três importantes deidrogenases em quatro cunhas de ovário micropolicístico humano. Comenta-se a importância dos estudos histoquímicos simultâneos das vias metabólicas inter-relacionadas. Observam-se, neste estudo histoquímico, a G6P-D hiperativa, a A-D II com atividade normal e a 3ßST-D com atividade reduzida. Sugere-se, ainda a participaçäo de bloqueios enzimáticos ovarianos no estabelecimento do feedback inadequado da síndrome dos ovários micropolicísticos (SOMP)


Subject(s)
Adult , Humans , Female , Hydroxysteroid Dehydrogenases/analysis , Ovary/enzymology , Polycystic Ovary Syndrome/pathology
18.
Indian J Physiol Pharmacol ; 1983 Jan-Mar; 27(1): 7-12
Article in English | IMSEAR | ID: sea-107718

ABSTRACT

The adult Wistar strain albino rats were vasectomised by conventional method and maintained for six months. The vasectomized rat testis had elevated water content with depleted dry matter. Glycogen content was increased with indication of mobilization of hexoses into HMP pathway. The vasectomized rat testis showed preferential utilisation of triglycerides. In view of increased 3 beta-HSD and 17 beta-HSD activities, accelerated androgenesis was envisaged in vasectomized rat testis.


Subject(s)
Animals , Cholesterol/blood , Fatty Acids, Nonesterified/blood , Glycerol/blood , Hydroxysteroid Dehydrogenases/metabolism , Lipids/blood , Male , Phospholipids/blood , Rats , Rats, Inbred Strains , Testis/metabolism , Triglycerides/blood , Vasectomy
SELECTION OF CITATIONS
SEARCH DETAIL